“Trend Management”

43 result(s)
Male patient holding a pill bottle and glass of water
Cost Management
CVS Caremark’s QALY-based program aims to bring rationality to drug pricing using comparative effectiveness research and cost-effectiveness analysis, and get manufacturers to set... More
Commentary
Cover image of the Whitepaper PDF document
Cost Management
CVS Health is proposing innovations that build on existing PBM techniques to help patients afford the medications they need and improving outcomes while lowering high drug maker... More
White Paper
Senior couple walking on a beach
Specialty
CVS Health’s three-tier specialty formulary design separates the increasingly more expensive specialty therapies into three distinct copay or coinsurance categories. Paired with... More
Briefing
Portrait photo of Jon Roberts speaking at the 2018 CVS Health Forum
Cost Management
Managed formulary strategies helped CVS Health clients contain drug price growth, lower trend and improve adherence in 2017. More
Video
Doctor with stethoscope, checking a patient's breating
Specialty
While the launch time is uncertain, potential PAH generics could give payors greater cost control opportunities for a complex, expensive condition requiring lifelong treatment. More
Briefing
Lady in high street
Cost Management
We want clients and members to get the most out of their benefit and the cost of a drug is aligned with the value it delivers. Despite AWP inflation near 10%, we kept drug price... More
Feature
Female mountain biker, rolling down a hill
Care Management
Earning third-party accreditations is part of our commitment to meeting strict quality standards, and focus on ongoing improvement to helping improve patient safety and improved... More
Briefing
Icon depicting a virus cell
Care Management
High drug costs, social stigma, complications, comorbidities, and complexity of medication regimen, make HIV a challenging disease. A whole-patient care management approach is... More
Briefing
Lady suffering from migraine, pressing hand against forehead
Drug Pipeline
The market for migraine medications is ripe for growth due to a large patient population with an unmet clinical need. Four investigational medications known CGRP inhibitors will... More
Feature
Icon depicting a virus cell
Specialty
HIV drugs are a $17 billion market and the pipeline has seen dramatic shifts in recent years. Ongoing monitoring, effective utilization management, and a focus on adherence can... More
Briefing